Speaker illustration

Doctor Marc Vanderheyden

Cardiovascular Center OLV Hospital Aalst, Aalst (Belgium)

Member of:

European Society of Cardiology
Heart Failure Association

Impact of eGFR slope upon mortality in a real world heart failure cohort

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Heart failure: determinants of outcome

Thumbnail

Detecting transthyretin amyloid cardiomyopathy in a real-world heart failure population: automated data extraction from electronic health records using natural language processing

Event: Heart Failure 2023

Topic: Epidemiology, Prognosis, Outcome

Session: ePosters in chronic heart failure - epidemiology, prognosis, outcome 3

Thumbnail

T cell and antibody response following double dose of BNT162b2 mRNA Vaccine in heart transplant recipients

Event: Heart Failure 2022

Topic: Heart Transplantation

Session: Heart Failure ePosters - focus on Chronic Heart Failure 6

Thumbnail

Real-world eligibility for dapagliflozin in unselected heart failure patients: data from the CORDIS-HF registry

Event: Heart Failure 2021

Topic: Pharmacotherapy

Session: ePoster session

Thumbnail

Functional mitral regurgitation in pts with HFrEF, HFmrEF and HFpEF: the good, the bad and the ugly ?

Event: Heart Failure 2019

Topic: Pathophysiology and Mechanisms

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Impact of functional mitral regurgitation at discharge upon survival in patients with acute decompensated HFpEF, HFmrEF and HFrEF

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

Differences in VWF activity in von willebrand disease type 2A patients versus LVAD patients with the acquired von willebrand syndrome.

Event: ESC Congress 2018

Topic: Ventricular Assist Devices

Session: Predictors of outcome after LVAD implantation

Thumbnail

Differential endomyocardial expression of SGLT1 in idiopathic dilated cardiomyopathy patients with and without diabetes mellitus.

Event: ESC Congress 2018

Topic: Pathophysiology

Session: Chronic heart failure – Pathophysiology and mechanisms

Thumbnail

Differential endomyocardial expression of SGLT1 in idiopathic dilated cardiomyopathy patients with and without diabetes mellitus.

Event: Heart Failure 2018

Topic: Pathophysiology

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Prognostic role of myocardial SERPINA3 and ST2 transcripts in predicting mortality in patients with heart failure due to idiopathic cardiomyopathy

Event: Heart Failure 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb